NORMAL SITUATION

PHARMA SERVICE BRABANT

Company — Normal situation.

Financial year 2024 · Closed on 16/10/2024

Net result-35,5 k €-114,4 %over 1 year
Gross margin-69,2 k €-118,1 %over 1 year
Equity3,6 M €-1,0 %over 1 year

Identity

Source · BCE/KBO

PHARMA SERVICE BRABANT is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0890.234.326
Legal form
Public limited company
Contributed capital
700 000,00 €
Latest accounts
16/10/2024
Joint committees (1)
  • 313
Signals
Solid equity

Financials

Source · NBB, 19 filings

Trend over 18 financial years

20242023202220212020
Income statement
Gross margin-69,2 k €382,2 k €1,5 M €1,2 M €1,2 M €
EBITDA-69,4 k €392,7 k €785 k €485,6 k €611,2 k €
Operating result-69,4 k €392,1 k €784,4 k €485 k €610,5 k €
Net result-35,5 k €246,3 k €606,9 k €252,2 k €334,4 k €
Balance sheet
Equity3,6 M €3,7 M €3,4 M €2,8 M €2,6 M €
Total assets3,6 M €5,5 M €7,5 M €6,6 M €6,7 M €
Cash3,6 M €5,5 M €99,3 k €5,9 k €88,3 k €
Debts–1,8 M €4,1 M €3,8 M €4,1 M €
Other
Workforce–0,0 ETP9,2 ETP11,7 ETP11,4 ETP

Board of directors

Source · NBB, accounts to 16/10/2024

3 active · 13 ended

Active mandates

Katleen Quisthoudt

Director · since 01 janvier 2018 · until 16 octobre 2024

Active
FEBELFARMA

Director · since 31 décembre 2017 · until 16 octobre 2024 · 0479.127.936

Represented by Frank Coene

Active
Kristien Doms

Managing director · since 19 juin 2007 · until 16 octobre 2024

Active

Ended mandates

Katleen Quisthoudt

Director · since 01 janvier 2018

Ended
FEBELFARMA

Director · since 31 décembre 2017 · 0479.127.936

Represented by Frank COENE

Ended
Kristien Doms

Managing director · since 19 juin 2007

Ended
CVBA FEBELFARMA

Director

Ended

Full financial information

Source · NBB
202420232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year16/10/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year10 months12 months12 months12 months12 months12 months
Filing date02/12/202429/07/202430/08/202329/07/202226/08/202131/08/2020
General meeting16/10/202406/06/202401/06/202302/06/202203/06/202104/06/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model16/10/202416/10/202402/12/2024DutchPDF
Abridged model31/12/202306/06/202429/07/2024DutchPDF
Abridged modelCorrection31/12/202201/06/202330/08/2023DutchPDF
Abridged model31/12/202201/06/202316/08/2023DutchPDF
Abridged model31/12/202102/06/202229/07/2022DutchPDF
Abridged model31/12/202003/06/202126/08/2021DutchPDF
Abridged model31/12/201904/06/202031/08/2020DutchPDF
Abridged model31/12/201806/06/201913/06/2019DutchPDF
Abridged model31/12/201707/06/201818/07/2018DutchPDF
Abridged model31/12/201601/06/201727/07/2017DutchPDF
Abridged model31/12/201502/06/201601/08/2016DutchPDF
Abridged model31/12/201430/06/201520/08/2015DutchPDF
Abridged model31/12/201330/06/201421/08/2014DutchPDF
Abridged model31/12/201230/06/201301/07/2013DutchPDF
Abridged model31/12/201130/06/201230/07/2012DutchPDF
Abridged model31/12/201029/08/201130/08/2011DutchPDF
Abridged model31/12/200908/07/201014/07/2010DutchPDF
Abridged model31/12/200804/06/200922/06/2009DutchPDF
Abridged model31/12/200705/06/200823/06/2008DutchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 16/10/2024

3 active · 13 ended

Active mandates

Katleen Quisthoudt

Director · since 01 janvier 2018 · until 16 octobre 2024

Active
FEBELFARMA

Director · since 31 décembre 2017 · until 16 octobre 2024 · 0479.127.936

Represented by Frank Coene

Active
Kristien Doms

Managing director · since 19 juin 2007 · until 16 octobre 2024

Active

Ended mandates

Katleen Quisthoudt

Director · since 01 janvier 2018

Ended
FEBELFARMA

Director · since 31 décembre 2017 · 0479.127.936

Represented by Frank COENE

Ended
Kristien Doms

Managing director · since 19 juin 2007

Ended
CVBA FEBELFARMA

Director

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution06/11/2024
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
    PDF
  • Mandates29/11/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office02/06/2023
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates25/06/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office23/09/2011
    MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates27/06/2011
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates17/12/2010
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-35,5 k €↓
  2. 2023
    Annual accounts 2023246,3 k €↓
  3. 2022
    Annual accounts 2022606,9 k €↑
  4. 2021
    Annual accounts 2021252,2 k €↓
  5. 2020
    Annual accounts 2020334,4 k €↑
  6. 2019
    Annual accounts 2019243,6 k €↑
  7. 2018
    Annual accounts 2018182,8 k €↓
  8. 2017
    Annual accounts 2017233 k €↑
  9. 2016
    Annual accounts 2016132,2 k €↓
  10. 2015
    Annual accounts 2015204,4 k €↑
  11. 2014
    Annual accounts 2014118,6 k €↑
  12. 2013
    Annual accounts 20135,4 k €↑
  13. 2012
    Annual accounts 2012-3,9 k €↓
  14. 2011
    Annual accounts 2011499,4 k €↑
  15. 2010
    Annual accounts 2010102,6 k €↑
  16. 2009
    Annual accounts 2009-69,1 k €↑
  17. 2008
    Annual accounts 2008-119 k €↓
  18. 2007
    Annual accounts 20071,3 k €